Pharmaceuticals

Strategic Report on Artificial Intelligence (AI) In Biopharmaceuticals Market: Growth Opportunities and Emerging Challenges

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Does the Forecast Indicate for the Artificial Intelligence (AI) In Biopharmaceuticals Market From 2025 to 2029?#_x000D_

In recent times, the market size for prostate cancer drugs has exhibited robust growth. The market is projected to expand from $18.53 billion in 2024 to $19.51 billion in 2025, equating to a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth during the historic period include an aging population, rising diagnosis rates, innovative drugs, enhanced awareness and education, as well as insurance and reimbursement policies._x000D_

_x000D_

The market size for prostate cancer drugs is anticipated to witness considerable expansion in the forthcoming years. The market is projected to escalate to “$24.63 billion in 2029 with a compound annual growth rate (CAGR) of 6.0%.” The market expansion during the forecast period can be credited to factors like an increasing incidence, the emergence of new markets, favorable governmental policies, and investment in research & development. The forecast period is expected to see key trends such as precision medicine, immunotherapy, targeted treatments, personalized medicine, clinical trials, drug pipelines, combination treatments, biomarker-oriented therapies, telemedicine, and remote supervision._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=2592&type=smp_x000D_

_x000D_

#What Elements Are Contributing To Growth In The Artificial Intelligence (AI) In Biopharmaceuticals Market?#_x000D_

The rise in chronic diseases is anticipated to fuel the expansion of the artificial intelligence (AI) in biopharmaceuticals market. Chronic illnesses are persisting conditions that usually advance gradually and can last for a number of years or even a lifetime. They are caused by lifestyle choices, an older demographic, hereditary factors, and environmental influences. AI in biopharmaceuticals is being increasingly utilized for the management of chronic illnesses due its capacity to process vast amounts of varied data sources, spot patterns, and customize treatment plans. For example, the Department of Health and Human Services reported in November 2023 that there was an 11 percent increase in newly reported cases of chronic Hepatitis B in 2022 compared to 2021, demonstrating the escalating prevalence of chronic diseases. This rise in chronic diseases is therefore propelling the growth of the artificial intelligence (AI) in biopharmaceuticals market._x000D_

_x000D_

The prostate cancer drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer _x000D_

2) By Therapy: Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy _x000D_

3) By End User: Hospitals, Clinics, Other End-Users _x000D_

_x000D_

Subsegments:_x000D_

1) By Hormone Sensitive Prostate Cancer: Early-Stage Prostate Cancer, Locally Advanced Prostate Cancer, Metastatic Prostate Cancer _x000D_

2) By Hormone Refractory Prostate Cancer: Castration-Resistant Prostate Cancer (CRPC), Metastatic Castration-Resistant Prostate Cancer (mCRPC)_x000D_

_x000D_

#What Trends Are Currently Influencing Growth In The Artificial Intelligence (AI) In Biopharmaceuticals Market?#_x000D_

The trend toward utilizing combination therapy for prostate cancer treatment is gaining momentum within the market, largely due to the inefficacy of monotherapy in some instances. Consequently, companies within the prostate cancer pharmaceutical industry are allocating more resources toward this treatment strategy. For instance, Pfizer disclosed the results of its Phase 3 PROSPER trial involving non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC) patients. The findings demonstrated that XTANDI (enzalutamide) combined with androgen deprivation therapy (ADT) substantially lowered the likelihood of metastases or death by 71%, in comparison to just using ADT alone. Analogous combined treatments such as radiation and androgen deprivation therapy are being employed for cases of recurrent prostate cancer, alongside the usage of docetaxel (Taxotere), a chemotherapy drug, in tandem with ADT._x000D_

_x000D_

#Who Are The Key Contributors To Growth In The Artificial Intelligence (AI) In Biopharmaceuticals Market?#_x000D_

Major companies operating in the prostate cancer drugs market include Astellas Pharma Inc., AstraZeneca PLC, Johnson & Johnson, Sanofi S.A., Bayer AG, F. Hoffmann-La Roche AG, Abbott Laboratories, Pfizer Inc., Novartis International AG, F. Hoffmann-La Roche Ltd., Tolmar Inc., AbbVie Inc., Siemens Healthineers AG, Genomic Health Inc., OPKO Health Inc., Siemens Healthcare GmbH, MDxHealth SA, Myriad Genetics Inc., Janssen Biotech Inc., Clovis Oncology Inc., Merck Sharp & Dohme Corp., Dendreon Corporation, Ferring Pharmaceuticals Inc., GlaxoSmithKline plc, Ipsen Biopharmaceuticals Inc., Merck & Co. Inc., Eli Lilly and Company Inc., Bausch Health Companies Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Novartis AG, Amgen Inc., Biogen Inc., Celgene Corporation, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Agios Pharmaceuticals Inc., Exelixis Inc._x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report_x000D_

_x000D_

#Which Region Is Projected To Lead The Artificial Intelligence (AI) In Biopharmaceuticals Market By 2025?#_x000D_

North America was the largest region in the prostate cancer drugs market in 2024. Middle East is expected to be the fastest-growing region in the prostate cancer drugs market during the forecast period. The regions covered in the prostate cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=2592&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_